Research Synthesis: Resveratrol Supplementation Effects — full paper

Researka accepted publication: 20fd4980-edf8-4f51-8e21-92a354934fc4 Source submission: fb5cbc7e-98c8-42d2-8792-c796d4a3f12a Evidence-honesty note: 11/14 retained sources are indirect, review-level, adjacent, or mechanistic and are used only to bound interpretation. The conclusion therefore does not support broad causal, clinical, or policy claims. This paper synthesizes evidence on resveratrol supplementation effects across 14 included source papers and 720 high-confidence extracted claims. The evidence profile contains 3 direct clinical sources, 3 adjacent clinical sources, and no sources classified primarily as mechanistic or model-system evidence, with 31 cross-study disagreements across the evidence base. Positive study-level signals are summarized in the immune, dosing and pharmacokinetics, cardiometabolic outcome classes, null signals in the dosing and pharmacokinetics, deficiency prevalence outcome classes, and negative signals in the dosing and pharmacokinetics outcome class. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect. The conclusion is that resveratrol supplementation effects should be treated as a bounded geroscience hypothesis: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.